Table 3.
Analytes with significant changes from baseline, over the follow up period.
| Analyte (condition) | Month 1a | Month 3a | Month 6a | Adj. P-Valb |
|---|---|---|---|---|
| IL-1beta (Ag-Nil) | −3,240.28 | −4,086.82 | −3,047.68 | 1.43E-03 |
| IL-1alpha (Ag-Nil) | −2,053.01 | −2,791 | −2,283.65 | 2.68E-03 |
| MCP-1 (Nil) | −1,152.4 | −1,263.36 | −791.29 | 2.68E-03 |
| IP-10 (Ag-Nil) | 22,221.56 | 929.38 | 47,674.16 | 1.61E-02 |
a
log-fold change between the concentration at baseline (day 0) and concentrations at 1, 3, and 6 months of ART respectively (negative value mean decrease and positive value means increase).
b
Adj. P-Val: P-value from Limma analysis, after adjustment for FDR.